Girish K Gupta
Overview
Explore the profile of Girish K Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osman N, Anwar M, Singh B, Gupta G, Rabie A
J Egypt Public Health Assoc
. 2023 Mar;
98(1):4.
PMID: 36859556
Coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) is responsible for a high mortality rate due to its unique and severe host-pathogen interactions. Critically ill or immunocompromised COVID-19 patients are more prone...
2.
Kumar D, Sharma P, Shabu , Kaur R, Lobe M, Gupta G, et al.
RSC Adv
. 2022 Apr;
11(29):17936-17964.
PMID: 35480193
The HIV/AIDS pandemic is a serious threat to the health and development of mankind, which has affected about 37.9 million people worldwide. The increasing negative health, economic and social impacts...
3.
Wilkin P, Al-Yozbaki M, George A, Gupta G, Wilson C
Curr Pharm Des
. 2020 Oct;
26(41):5261-5277.
PMID: 33059564
On 11th March 2020, the World Health Organisation (WHO) announced a pandemic caused by a novel beta-coronavirus SARS-CoV-2, designated COVID-19. The virus emerged in December 2019 in Wuhan, China, has...
4.
Kaur R, Sharma P, Gupta G, Ntie-Kang F, Kumar D
Molecules
. 2020 May;
25(9).
PMID: 32365518
Acquired Immunodeficiency Syndrome (AIDS), which chiefly originatesfroma retrovirus named Human Immunodeficiency Virus (HIV), has impacted about 70 million people worldwide. Even though several advances have been made in the field...
5.
Sharma A, Sharma V, Gupta G, Ashraf G, Kamal M
Curr Drug Metab
. 2018 Sep;
20(1):65-71.
PMID: 30207227
Background: Advanced Glycation End products (AGEs) are basically the end result of glycation of proteins and/or lipids in the presence of sugars. Specific cases of hyperglycemia have been reported with...
6.
Kumar D, Sharma P, Nepali K, Mahajan G, Mintoo M, Singh A, et al.
Heliyon
. 2018 Jul;
4(6):e00661.
PMID: 30003157
In an effort to discover an effective and selective antitumour agent, synthesis and anti-cancer potential of 4-(pyridin-4-yl)-6-(thiophen-2-yl) pyrimidin-2(1)-one (), which has been reported earlier by us with significant cytotoxicity towards...
7.
El Arbi M, Ketata E, Neifar A, Mihoubi W, Gupta G, Pigeon P, et al.
Mini Rev Med Chem
. 2017 Feb;
18(15):1294-1301.
PMID: 28183263
Background & Objective: The inhibitory effects of four series of aryl butene derivatives, active against breast cancer, on the monophenolase activity of tyrosinase, in melanin-free ink from Sepia officinalis, have...
8.
Double Edge Sword Behavior of Carbendazim: A Potent Fungicide With Anticancer Therapeutic Properties
Goyal K, Sharma A, Arya R, Sharma R, Gupta G, Sharma A
Anticancer Agents Med Chem
. 2016 Dec;
18(1):38-45.
PMID: 28003000
Background: A number of benzimidazole derivatives such as benomyl and carbendazim have been known for their potential role as agricultural fungicides. Simultaneously carbendazim has also been found to inhibit proliferation...
9.
Singh S, Banala V, Gupta G, Verma A, Shukla R, Pawar V, et al.
Drug Dev Ind Pharm
. 2015 Feb;
41(11):1759-68.
PMID: 25686725
The aim of this study was to fabricate docetaxel loaded nanocapsules (DTX-NCs) with a high payload using Layer-by-Layer (LbL) technique by successive coating with alternate layers of oppositely charged polyelectrolytes....
10.
Chandna N, Kumar S, Kaushik P, Kaushik D, Roy S, Gupta G, et al.
Bioorg Med Chem
. 2013 Jun;
21(15):4581-90.
PMID: 23769654
Two series of celecoxib analogues having 1,5-diaryl relationship were synthesized. The key strategy of the molecular design was oriented towards exploring bioisosteric modifications of the sulfonamide moiety of celecoxib. First...